Nicolas Dorvault

1.3k total citations
12 papers, 237 citations indexed

About

Nicolas Dorvault is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Nicolas Dorvault has authored 12 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Nicolas Dorvault's work include DNA Repair Mechanisms (4 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Nicolas Dorvault is often cited by papers focused on DNA Repair Mechanisms (4 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Nicolas Dorvault collaborates with scholars based in France, Italy and United Kingdom. Nicolas Dorvault's co-authors include Ken A. Olaussen, Luc Friboulet, Fabrice André, Sophie Postel‐Vinay, Julien Adam, Christopher J. Lord, Frédéric Commo, Richard Elliott, Alan Ashworth and Jean‐Charles Soria and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Nicolas Dorvault

12 papers receiving 233 citations

Peers

Nicolas Dorvault

ONCOL

PRM

PFM

Sarah Ftouni Australia

Aleksandra Filipović United Kingdom

Xue Zheng China

Vasudeva Bhat Canada

Madhumathy G Nair India

Sara S. Oltra Spain

Francesca Citron Italy

Yunshi Zhong China

Tonći Šuštić Netherlands

Biao He United States

Sarah Ftouni Australia

Nicolas Dorvault

113 ×0.7

94 ×0.8

ONCOL

100 ×1.5

65 ×1.4

PRM

36 ×1.4

PFM

Citations per year, relative to Nicolas Dorvault Nicolas Dorvault (= 1×) peers Sarah Ftouni

Countries citing papers authored by Nicolas Dorvault

Since Specialization

Citations

This map shows the geographic impact of Nicolas Dorvault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Dorvault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Dorvault more than expected).

Fields of papers citing papers by Nicolas Dorvault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Dorvault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Dorvault. The network helps show where Nicolas Dorvault may publish in the future.

Co-authorship network of co-authors of Nicolas Dorvault

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Dorvault. A scholar is included among the top collaborators of Nicolas Dorvault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Dorvault. Nicolas Dorvault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chabanon, Roman M., Daphné Morel, Léo Colmet‐Daage, et al.. (2020). Abstract 1058: Targeting chromatin remodeling-associated genetic vulnerabilities in cancer: PBRM1 defects are synthetic lethal with PARP and ATR inhibitors. Cancer Research. 80(16_Supplement). 1058–1058. 2 indexed citations

Kuo, Mei-Shiue, Julien Adam, Nicolas Dorvault, et al.. (2018). A novel antibody-based approach to detect the functional ERCC1-202 isoform. DNA repair. 64. 34–44. 6 indexed citations

Kossaï, Myriam, Gwénaël Le Teuff, Marc Deloger, et al.. (2017). MA11.02 Mutational Burden in Pulmonary Neuroendocrine Tumors (puNETs). Journal of Thoracic Oncology. 12(1). S404–S404. 2 indexed citations

Deloger, Marc, Ludovic Lacroix, Bastien Job, et al.. (2016). Genomic profile in pulmonary neuroendocrine tumors (puNETs): the whole-exome sequencing (WES) as a strategic tool. Annals of Oncology. 27. vi137–vi137. 1 indexed citations

Berthet, Nicolás, Lionel Frangeul, Ken A. Olaussen, et al.. (2015). No evidence for viral sequences in five lepidic adenocarcinomas (former “BAC”) by a high-throughput sequencing approach. BMC Research Notes. 8(1). 782–782. 3 indexed citations

Friboulet, Luc, Sophie Postel‐Vinay, Tony Sourisseau, et al.. (2013). ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform. Cell Cycle. 12(20). 3298–3306. 38 indexed citations

Postel‐Vinay, Sophie, Ilirjana Bajrami, Luc Friboulet, et al.. (2013). A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer. Oncogene. 32(47). 5377–5387. 65 indexed citations

Galluzzi, Lorenzo, Aïcha Goubar, Ken A. Olaussen, et al.. (2013). Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle. 12(4). 647–654. 16 indexed citations

Planchard, David, Valérie Camara‐Clayette, Nicolas Dorvault, Jean‐Charles Soria, & Pierre Fouret. (2012). p38 mitogen‐activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients. Cancer. 118(20). 5015–5025. 18 indexed citations

10.

Auger, Nathalie, B. Lueza, Frédéric Commo, et al.. (2012). ALK amplification and crizotinib sensitivity in non-small cell lung cancer cell lines and patients report.. Journal of Clinical Oncology. 30(15_suppl). 10556–10556. 9 indexed citations

11.

Friboulet, Luc, Frédéric Commo, Ken A. Olaussen, et al.. (2011). Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC. Clinical Cancer Research. 17(17). 5562–5572. 54 indexed citations

12.

Loriot, Yohann, Pierre Mordant, Nicolas Dorvault, et al.. (2010). BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation. British Journal of Cancer. 103(3). 347–353. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact